]>
IRCT20171109037332N1 IRCT 2018-01-06 Kerman University of Medical Sciences Comparison of the effect of Ibuprofen, Naufafen, Mefenamic acid and Celecoxib on the improvement of dental pain in the stage before the endodontic emergencies A comparative study of analgesic effects of Ibuprofen, Novafen, Mefenamic acid and Celecoxib in relieving pain of symptomatic pulpitis before emergency endodontic intervention 2017-12-01 anticipated 120 Complete https://irct.ir/trial/27649 interventional Randomization: N/A, Blinding: Triple blinded, Placebo: Not used, Assignment: Parallel, Purpose: Other, Blinding description: In each group, the company will take 30 pills of powdered detergents and will be placed inside a blank capsule. So that both the project executives and the patients will be unaware of the type of medication. Also, the code of the drug groups will be revealed and determined after the statistical review. The statistician will also be aware of the type of medication and the groups being studied. N/A symptomatic pulpitis. Intervention 1: First Intervention group: Ibuprofen 400 once. Intervention 2: Second intervention group: Novafer once, containing 325 mg of acetaminophen, 40 mg of caffeine and 200 mg of ibuprofen. Intervention 3: Third intervention group: Mefenamic acid 250 once. Intervention 4: Fourth intervention group: Celecoxib 200 once. Yes - There is a plan to make this available What will be shared: The total potential data can be shared after unidentifiable peopleav,u n, When: Start the access period 6 months after printing the results To whom: Data will only be available to researchers in academia and academia Conditions: There are no other conditions for using data Where to obtain: Homa Kamyabi, h.kamyabi1244@gmail.com Dr Rahim Fereidooni, rahim.fereidooni71@yahoo.com Dr Arash Shahravan,l arashahravan@gmail.com How to obtain: The applicant sends emails to each researcher and their introduction and reasons for requesting data at the latest after one month of data Comments:
public Homa kamyabi
Shafa St., School of Dentistry
kerman Iran (Islamic Republic of) 7618759689 +98 34 3211 9028 h.kamyabi1244@gmail.com Kerman University of Medical Sciences scientific arash shahravan
Shafa St., Faculty of Dentistry
kerman Iran (Islamic Republic of) 7618759689 +34 32119028 arashahravan@gmail.com Kerman University of Medical Sciences Iran (Islamic Republic of) The patient has an irreversible acute pulpitis, diagnosed by a dentist; Lack of medical problem (20) (such as history of stroke or heart failure, heart failure, blood pressure, asthma, nasal polyps, liver or kidney disease, gastric ulcer, systemic lupus, blood clotting problems, etc.); Access to the patient; Patients without oral disease and history of corticosteroid susceptibility are nonsteroidal inflammation; The teeth should be permanent with closed apex; Failure to quickly deal with endodontic emergencies; Patient satisfaction and compliance form completion 18 years no limit Both Patients who have received a home for up to 6 hours before; Patients who for any reason prohibit the use of the drugs studied. K04.0 pulpitis Other Other Other Other First Intervention group: Ibuprofen 400 once Second intervention group: Novafer once, containing 325 mg of acetaminophen, 40 mg of caffeine and 200 mg of ibuprofen. Third intervention group: Mefenamic acid 250 once Fourth intervention group: Celecoxib 200 once Intensity of pain. Timepoint: Measure the severity of pain at the beginning of the study (before the intervention) and 1 hour after taking the drug. Method of measurement: Visual Analogue Scale. Kerman University of Medical Sciences Approved 2017-11-17 Ethics Committee of Kerman University of Medical Sciences Blvd.Heft Gardens Alavi-Pardis University of Medical Sciences kerman Kerman Iran (Islamic Republic of)